Methylenedioxyallylamphetamine

MDAL
Clinical data
Other names	MDAL; 3,4-Methylenedioxy-N-allylamphetamine
Routes of; administration	Oral
ATC code	None;
Pharmacokinetic data
Duration of action	Unknown
Identifiers
	IUPAC name N-[1-(2H-1,3-benzodioxol-5-yl)propan-2-yl]prop-2-en-1-amine;
CAS Number	74698-45-6 ;
PubChem CID	44719581 ;
ChemSpider	21106331 ;
UNII	HYC85U2R8Z ;
CompTox Dashboard (EPA)	DTXSID40660369 ;
Chemical and physical data
Formula	C13H17NO2
Molar mass	219.284 g·mol−1
3D model (JSmol)	Interactive image ;
	SMILES C1=C2C(=CC=C1CC(C)NCC=C)OCO2;
	InChI InChI=1S/C13H17NO2/c1-3-6-14-10(2)7-11-4-5-12-13(8-11)16-9-15-12/h3-5,8,10,14H,1,6-7,9H2,2H3 ; Key:BMKCDDFQEGYEJC-UHFFFAOYSA-N ;
	(what is this?) (verify)

Last updated February 23, 2026

Methylenedioxyallylamphetamine (MDAL or 3,4-methylenedioxy-N-allylamphetamine) is a lesser-known drug.^[1]^[2]^[2] It is the N-allyl derivative of 3,4-methylenedioxyamphetamine (MDA).^[1]^[2]

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDAL's minimum dose as 180 mg orally and its duration as unknown.^[1]^[2] MDAL produces few to no effects on its own, but may enhance the effects of psychedelic drugs like LSD.^[1]

Society and culture

Legal status

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.^[3]

References

1 2 3 4 5 6 Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. MDAL entry
1 2 3 4 Shulgin AT (2003). "Basic Pharmacology and Effects". In Laing RR (ed.). Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN 978-0-12-433951-4. Archived from the original on 13 July 2025.
↑ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.

External links

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[PiHKAL-1] 1 2 3 4 5 6 Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. MDAL entry

[Shulgin2003-2] 1 2 3 4 Shulgin AT (2003). "Basic Pharmacology and Effects". In Laing RR (ed.). Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN 978-0-12-433951-4. Archived from the original on 13 July 2025.

[3] "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.

[1]

[2]

[3]